Dr. Almeida is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
410 Cowart Avenue
Valdosta, GA 31602Phone+1 229-244-6544Fax+1 229-241-9744
Summary
- Dr. Nestor Almeida is a nephrologist in Valdosta and Cordele, GA. He received his medical degree from the Industrial University of Santander Faculty of Medicine in Colombia, South America. He is a nephrologist and internist who did his nephrology training at The University of Utah and Internal Medicine Residency at Saint John's Episcopal Hospital South Shore Program (SUNY Down State, NY). And he has been in practice for 24 years. He also speaks Spanish. He is experienced in chronic kidney disease, acute renal failure, renal replacement therapy (RRT) like hemodialysis, Peritoneal dialysis, CRRT, glomerulonephritis, acid-base disorders, electrolyte disorders, metabolic syndrome, kidney biopsy, and chronic renal failure.
Education & Training
University of Utah HealthFellowship, Nephrology, 2011 - 2014
St John's Episcopal Hospital-South ShoreResidency, Internal Medicine, 2008 - 2011
Saint Joseph HospitalResidency, Internal Medicine, 2003 - 2004
Universidad de Antioquia/Hospital San Vicente de PaulInternship, 1995 - 2000
Industrial University of Santander Faculty of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 2024 - 2026
UT State Medical License 2011 - 2026
GA State Medical License 2022 - 2025
MP State Medical License 2023 - 2025
MD State Medical License 2023 - 2024
NE State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Nephrology
Awards, Honors, & Recognition
- National Kidney Foundation (NKF), Postdoctoral Research Fellowships (Mitsubishi Tanabe Pharma Corporation Fellowship for the Study of Uremia). University of Utah, July 2011 to June 2013. National Kidney Fundation (NKF), 2011-2013
- Award Dr. Lewis Cuni, M.D. Best Internal Medicine Resident 2011, Saint John’s Episcopal Hospital South-Shore Program, Far Rockaway, New York. June 2011 Saint John's Episcopal Hospital, 2011
- Supplemental Minority Grant. National Institute of Health (NIH)/ NIDDK, to study the effects of COX-2 inhibition on the gamma subunit of the Na/K ATPase or FXYD2. July 2004 to June 2006. National institute of Health (NIH), 2004-2006
Clinical Trials
- Effects of High Dietary Fiber Supplementation in Diabetic Chronic Kidney Disease Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- 44 citationsAssociations of Body Size and Body Composition with Functional Ability and Quality of Life in Hemodialysis PatientsMacy Martinson, T. Alp Ikizler, Glen Morrell, Guo Wei, Nestor Almeida
Clinical Journal of the American Society of Nephrology. 2014-06-06 - 40 citationsThe tight junction protein, MUPP1, is up-regulated by hypertonicity and is important in the osmotic stress response in kidney cells.Miguel A. Lanaspa, Nestor E. Almeida, Ana Andres-Hernando, Christopher J. Rivard, Juan M. Capasso
Proceedings of the National Academy of Sciences of the United States of America. 2007-08-21 - 8 citationsThe gamma subunit of Na/K-ATPase: an exceptional, small transmembrane protein.Christopher J. Rivard, Nestor E. Almeida, Tomas Berl, Juan M. Capasso
Frontiers in Bioscience. 2005-09-01
Authored Content
- MOC: NBPAS vs. ABMS. Response from ABMS to DOJ about certification competition10/14/2018
Grant Support
- National Kidney Foundation (NKF), Postdoctoral Research Fellowships (Mitsubishi Tanabe Pharma Corporation Fellowship for the Study of Uremia). University of Utah, July 2011 to June 2013.National Kidney Foundation (NKF) Mitsubishi Tanabe Pharma Corporation Fellowship for the Study of Uremia.2011–2013
- Minority Grant from the NIH Supplemental Minority Grant. National Institute of Health (NIH)/ NIDDK, to study the effects of COX-2 inhibition on the gamma subunit of the Na/K ATPase or FXYD2. July 2004 to June 2006.National Institute of Health (NIH)/NIDDK2004–2006
Research History
- Post-doctoral Research FellowI worked at the Osmo-regulation Lab at the University of Colorado, with Drs. Tomas Berl, MD/Christopher Rivard/Juan Capasso. There, I was awarded a Supplemental Minority Grant from the National Institute of Health (NIH) to study COX-2 inhibitors and Osmo-regulation using cellular animal models.2004 - 2009
Professional Memberships
- Member
- Fellow
- Member
- Member
Other Languages
- Spanish
Industry Relationships
- Advisory Board Member, Horizon PharmaMember at Nephrology Insights Advisory Board (ASN 2018) October 28th, 20018, San Diego, CADisclosure: Member at Nephrology Insights Advisory Board (ASN 2018) October 28th, 20018, San Diego, CA2018 - 2019
External Links
- Linkedinhttps://www.linkedin.com/in/nestor-almeida-m-d-99945a30/
- ORCIDhttps://orcid.org/0000-0001-6907-6028
- Renal Care 360https://renalcare360.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
